Insider Transactions in Q4 2023 at Palisade Bio, Inc. (PALI)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2023
|
John David Finley CEO, CFO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,559
+8.07%
|
-
|
|
Nov 20
2023
|
John David Finley CEO, CFO, Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+14.75%
|
$0
$0.51 P/Share
|
|
Nov 07
2023
|
Mitchell Lawrence Jones Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,630
-35.78%
|
$0
$0.54 P/Share
|
|
Nov 06
2023
|
John David Finley CEO, CFO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,475
+6.78%
|
-
|
|
Nov 06
2023
|
Mitchell Lawrence Jones Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,556
+50.0%
|
-
|
|
Oct 04
2023
|
John David Finley CEO, CFO, Director |
SELL
Payment of exercise price or tax liability
|
Direct |
397
-0.89%
|
$0
$0.55 P/Share
|
|
Oct 03
2023
|
John David Finley CEO, CFO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,309
+2.84%
|
-
|